Mariner LLC purchased a new position in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 5,893 shares of the company's stock, valued at approximately $781,000.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in ALAB. Vanguard Group Inc. lifted its position in shares of Astera Labs by 354.9% during the 4th quarter. Vanguard Group Inc. now owns 9,211,630 shares of the company's stock worth $1,220,080,000 after purchasing an additional 7,186,582 shares during the last quarter. Alliancebernstein L.P. raised its stake in Astera Labs by 2,328.5% in the fourth quarter. Alliancebernstein L.P. now owns 3,922,278 shares of the company's stock valued at $519,506,000 after buying an additional 3,760,765 shares in the last quarter. Jennison Associates LLC acquired a new stake in Astera Labs in the fourth quarter valued at $229,991,000. Norges Bank purchased a new stake in Astera Labs during the 4th quarter worth about $179,229,000. Finally, Massachusetts Financial Services Co. MA increased its holdings in shares of Astera Labs by 418.3% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 1,674,000 shares of the company's stock valued at $221,721,000 after acquiring an additional 1,351,007 shares during the last quarter. Institutional investors and hedge funds own 60.47% of the company's stock.
Insiders Place Their Bets
In other Astera Labs news, CFO Michael Truett Tate sold 125,800 shares of the firm's stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $82.53, for a total transaction of $10,382,274.00. Following the completion of the transaction, the chief financial officer now owns 244,242 shares of the company's stock, valued at approximately $20,157,292.26. This trade represents a 34.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Manuel Alba sold 63,000 shares of the business's stock in a transaction on Wednesday, April 2nd. The stock was sold at an average price of $63.37, for a total value of $3,992,310.00. Following the completion of the transaction, the director now directly owns 444,863 shares of the company's stock, valued at approximately $28,190,968.31. This trade represents a 12.40 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 633,990 shares of company stock worth $54,235,012.
Wall Street Analyst Weigh In
A number of brokerages recently issued reports on ALAB. Northland Capmk raised Astera Labs from a "hold" rating to a "strong-buy" rating in a report on Tuesday, January 28th. Stifel Nicolaus lowered their target price on shares of Astera Labs from $150.00 to $100.00 and set a "buy" rating for the company in a report on Thursday, April 17th. Citigroup cut their price target on shares of Astera Labs from $120.00 to $100.00 and set a "buy" rating on the stock in a research note on Monday, April 14th. Morgan Stanley decreased their price objective on shares of Astera Labs from $142.00 to $114.00 and set an "equal weight" rating for the company in a research note on Tuesday, January 28th. Finally, Barclays raised their price objective on Astera Labs from $87.00 to $135.00 and gave the stock an "overweight" rating in a report on Friday, January 17th. One research analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Buy" and an average price target of $109.25.
Read Our Latest Research Report on ALAB
Astera Labs Trading Down 0.5 %
Shares of NASDAQ:ALAB traded down $0.34 during midday trading on Wednesday, hitting $65.31. The stock had a trading volume of 1,708,838 shares, compared to its average volume of 3,816,690. The company has a market capitalization of $10.59 billion and a PE ratio of -37.75. Astera Labs, Inc. has a 1 year low of $36.22 and a 1 year high of $147.39. The stock has a 50 day moving average price of $65.42 and a two-hundred day moving average price of $91.34.
Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its earnings results on Monday, February 10th. The company reported $0.10 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.26 by ($0.16). Astera Labs had a negative return on equity of 10.40% and a negative net margin of 21.05%. As a group, equities analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current year.
About Astera Labs
(
Free Report)
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Featured Articles
Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
